The KCC Unicorn Contest is the first activity of the $500 million Ecosystem Accelerator Plan, as well as KCC’s first incentive program in 2022. Its goal is to find the best projects from various streams and channels in order to improve the on-chain ecosystem. In addition, the contest itself gives considerable financial assistance, with the […]
NEW YORK, Apr 22, 2022 - (ACN Newswire) - Beyond Imagination, Inc. is building humanoid robots to solve the world's labor crisis by expanding access to jobs around the globe.
This week, the Beomni robot will appear at Explorers Club Headquarters and at the annual dinner on Saturday April 23rd in New York City. At the same time, across the country in Beverly Hills, CA, attendees at the Abundance360 Annual Summit will be able to remotely pilot the robot from 2,800 miles away.
Beomni is the world's most sophisticated general-purpose humanoid robot, capable of performing an almost unlimited number of tasks. Beomni's AI Brain learns from its human pilots and becomes increasingly autonomous over time.
Beomni will help solve the labor crisis by creating a global elastic labor force, lifting millions of people out of poverty by giving them access to jobs around the world. For example, the International Labour Organization (ILO) reports that "More than 2.3 million workers die every year as a result of occupational accidents or work-related diseases." With Beomni, dangerous work will become completely safe because the robot will be the one taking the risks.
Elder Care is a $932B market today. We will help solve the elder crisis by enabling families to care for their own regardless of the distance between them and by multiplying the effectiveness of existing health care workers.
CEO and Founder Dr. Harry Kloor says, "We are thrilled to have been invited to demonstrate the advances we've made in Beomni's development at the Explorers Club. Beomni will be a great vehicle for explorers on earth and beyond! We share the spirit of exploration and discovery that is the hallmark of the Explorers Club."
Astronaut and Explorers Club President Richard Garriott adds, "For the last decade, I have been a power USER of early telepresence robotics devices, so I deeply appreciate the advancements in Beomni. We welcome the opportunity to showcase Dr. Kloor's creation alongside other world-changing technologies at our event. Smart technologies like Beomni will play an important part in helping solve the challenges the world is facing. On Earth, in space and on planets beyond Earth, robots like Beomni will play an essential role!"
The robot will be on display all week at the Explorers Club headquarters so members can have an opportunity to pilot it. On Saturday, Beomni will move to The Glass House, where the annual dinner is being held. Beomni will be serving drinks and hors d'oeuvres at the reception, and at the afterparty guests will also have the opportunity to pilot the robot.
Meanwhile, across the country in Beverly Hills, a second Beyond Imagination team will be set up at the Abundance360 Annual Summit. From there, Beomni will be operated from coast to coast. Members in attendance at the A360 Summit will be able to perform tasks, pick up and examine objects and even shake someone's hand across the country.
Abundance360 Founder, Peter Diamandis remarked, "Beyond Imagination dramatically changes the paradigm of how companies will provide services in the future, how and where you will receive healthcare, where you work and play."
About Beyond Imagination, Inc.
Beyond Imagination is a robotics and AI platform company that is focused on bringing humanoid robots to market rapidly. By partnering a human pilot with an evolving AI Brain, we will soon be able to deploy our Beomni Robotics platform across a wide range of commercial applications. Our practical, real-world approach is closer to that of Tesla, which released its vehicles and then built AI from the data that they collected, rather than that of other companies that are focused on narrow R&D domains.
Founded by leading innovators in AI and robotics, and strengthened by a solid patent portfolio, Beyond Imagination, Inc. is poised to revolutionize life and fundamentally change the way we work, travel and engage with others around the world.
Beyond Imagination is actively seeking business partners and investors for its Series A round. Details will be provided to qualified investors upon request. In-person demos are available by appointment for media and investors. Beyond Imagination is also seeking additional partners for pilot studies in medicine and beyond.
About The Explorers Club
Since its inception in 1904, members of the Club have traversed the earth, the seas, the skies, and even the moon, on expeditions. First to the North Pole, first to the South Pole, first to the summit of Mount Everest, first to the deepest point in the ocean and first to the surface of the moon - all accomplished by Explorers Club Members. Notable members include Teddy Roosevelt, Neil Armstrong, Jane Goodall, Edmund Hillary, John Glenn, Sally Ride, Bob Ballard, and more. https://www.explorers.org/
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comBeyond Imagination, Inc. is building humanoid robots to solve the world's labor crisis by expanding access to jobs around the globe.
SINGAPORE, Apr 22, 2022 - (ACN Newswire) - Catalist-listed AcroMeta Group Limited (ACROMETA; SGX: 43F), today announced that its wholly owned subsidiary AcroMec Engineers Pte Ltd (ACROMEC) has won a $31 million contract for the fit-out of an additional floor within the existing integrated advanced manufacturing facility in Singapore of a leading high-tech customer. When completed in 2023, the expansion will substantially increase its manufacturing capacity.
ACROMEC's specialties in controlled environment engineering
The ability to succinctly and precisely control physical variables such as temperature, air purity, humidity, and pressure in facility, like the product manufacturing space is a mission critical requirement. ACROMEC is ready to take on this project with the requisite track record, having completed numerous projects in clean rooms, laboratories and advanced manufacturing facilities.
Completion of previously announced project for Nasdaq-listed Genscript Biotech's Singapore R&D and manufacturing facility
ACROMEC'S strong track record is also seen having, earlier on, successfully completed the prestigious contract for the design and construction of Genscript's R&D and production laboratory facilities where they are used for the manufacture of the first-in-world C-Pass Serological Test Kit by the Duke University-NUS Medical School collaboration. C-Pass is a game-changing blood testing kit that determine a person's level of immunity against COVID-19 after vaccination.
Strong outlook for ACROMETA's controlled environment engineering business
ACROMETA Co-Founder, Chairman and CEO Lim Say Chin is heartened by the sizeable contract win. It reflects well on the high level of confidence that our Customer has on us. He said, "We are optimistic on the growth of our controlled environment business. Our business is well positioned for the Post-COVID world. We are having more customers investing in building facilities again for the future, both to prepare for the next pandemic and to prepare for technological growth. Indeed, we see activities building up in the biotechnology and semiconductor sectors, and we are glad to serve this space."
The contract is expected to commence soon and will materially contribute positively to the earnings per share and net tangible assets per share of the Group for the financial year ending 30 September 2022.
About AcroMeta Group Limited [SGX: 43F] [RIC: ACRI.SI] [BB: ACRO.SP]
AcroMeta Group Limited (previously AcroMec Limited) is an established specialist engineering services provider with more than 20 years of experience in the field of controlled environments. The Group has over the years acquired expertise in the design and construction of facilities requiring controlled environments such as laboratories, medical and sterile facilities and cleanrooms.
ACROMETA's business is divided into two main segments: (i) Engineering, procurement, and construction services, specialising in architectural, and mechanical, electrical and process works within controlled environments; and (ii) Maintenance and repair services of facilities and equipment of controlled environments and their supporting infrastructure.
The Group mainly serves the healthcare, biotechnology, pharmaceutical, research and academia, and electronics sectors. ACROMETA counts amongst its customers, hospitals and medical centres, government agencies, research and development companies or agencies, research and development units of multinational corporations, tertiary educational institutions, pharmaceutical companies, semiconductor manufacturing companies, and multinational engineering companies.
The company has been listed on the Catalist board of the SGX since 2016, and became AcroMeta Group Limited (previously AcroMec Limited) on February 18, 2022. For more information, please visit www.acrometa.com.
Media and Analysts Contact: ACROMETA Group Limited Mr Jerry Tan Chief Financial Officer Tel: +65 6415 0574 Email: firstname.lastname@example.org
This media release has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.
The contact person for the Sponsor is Mr. Joseph Au, 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318, email@example.com.
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comCatalist-listed AcroMeta Group Limited (ACROMETA; SGX:43F), today announced that its wholly owned subsidiary AcoMec Engineers Pte Ltd (ACROMEC) has won a $31 million contract for the fit-out of an additional floor within an existing integrated advanced manufacturing facility in Singapore of a leading high-tech customer.